The circadian clock gene BMAL1 is a novel therapeutic target for malignant pleural mesothelioma.
Elshazley M, Sato M, Hase T, Yamashita R, Yoshida K, Toyokuni S, Ishiguro F, Osada H, Sekido Y, Yokoi K, Usami N, Shames DS, Kondo M, Gazdar AF, Minna JD, Hasegawa Y.
Elshazley M, et al. Among authors: hase t.
Int J Cancer. 2012 Dec 15;131(12):2820-31. doi: 10.1002/ijc.27598. Epub 2012 May 14.
Int J Cancer. 2012.
PMID: 22510946
Free PMC article.